Search - tctmd.com

Displaying 101 - 120 of 479

Sort: Relevancy | Date

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News ACC 2024

ADHD Meds Linked to Cardiomyopathy in Young Adults

Todd Neale

April 01, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

Presentation THT 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

L.A. McKeown

February 29, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Advertisement

Wearable-Tracked Walking Behavior Hints at Subclinical HF

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

ADHD Meds Linked to Cardiomyopathy in Young Adults

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Cognitive Impairment a Real Concern in HF Patients: HFSA

Physicians (Mostly) Negative on Private Equity in Healthcare

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Debating the Role of T-TEER in the Sickest Patients

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

March 2024 Dispatch for the CV Team

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content